Trump Administration's Drug Policy Prioritizes Trafficking Over Cannabis Reform
Trump administration prioritizes drug trafficking and opioid epidemic over cannabis reform in new policy goals. Impact on cannabis industry and investors. TerrAscend Corp. among companies affected.
This news highlights the current stance of the Trump administration towards cannabis reform, indicating a shift in priorities towards more pressing drug-related issues. The decision not to prioritize marijuana rescheduling will have implications for the cannabis industry and investors, shaping the regulatory landscape and market dynamics.
